Buys
Open market- Shares
- Avg price
- Total value
Evan Lippman - EVP, Business Development at TEVA PHARMACEUTICAL INDUSTRIES LTD
Issuer-level insider activity
- Role
- EVP, Business Development
- Issuer symbol
- TEVA on NYSE, TEVJF on OTC
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
Past-year transaction volume for Evan Lippman in TEVA PHARMACEUTICAL INDUSTRIES LTD
Sells
Open market- Shares
- -41,658
- Avg price
- $35.58
- Total value
- -$1,482,367
Net
Past year- Shares
- -41,658
- Share %
- -100%
- Total value
- -$1,482,367
Reported holdings for Evan Lippman in TEVA PHARMACEUTICAL INDUSTRIES LTD
Form 4 holding
EVP, Business Development
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Ordinary Shares
- Shares / value
- 44,191
- Estimated value
- $1,572,501
- Report date
- 14 May 2026
- Price
- $35.58
- Ownership
- Direct
Form 4 holding
EVP, Business Development
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Restricted Share Units
- Shares / value
- 74,008
- Estimated value
- Report date
- 14 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Evan Lippman in TEVA PHARMACEUTICAL INDUSTRIES LTD
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.